Equity Subscription to raise £300,000

Mollyroe plc has raised £300,000 (before costs) by issuing 120,000,000 new ordinary shares at £0.0025 per share, with subscribers receiving 1:1 warrants exercisable at the same price and valid for four years; admission on Aquis Growth Market is expected around 16 February 2026. The company will have 160,275,480 shares outstanding post-admission and intends to deploy the proceeds alongside existing cash to execute its AI-focused investment strategy (including its Cascade Studio holding), fund working capital, and potentially alongside a forthcoming convertible loan on similar terms; board hires (CEO and Chief Innovation Officer) are in final stages. The round attracted new sophisticated investors, signalling supportive investor sentiment but the funding size is modest relative to public-market movers.

Analysis

Market structure: The subscription massively increases Mollyroe’s share count from 40,275,480 to 160,275,480 — existing holders are diluted to ~25.1% of post-money equity, and the 120m 1:1 warrants could push original ownership to ~14.4% if exercised. Direct winners are incoming sophisticated investors and portfolio companies (e.g., Cascade Studio) that receive runway; direct losers are legacy retail holders facing >75% of post-money float as newly issued paper, creating near-term selling pressure. The pricing power remains nil for Mollyroe; the key arb is execution on M&A/venture targets to justify the new float and warrants.

Risk assessment: Immediate tail risks include failure to finalize the Convertible Loan Note (CLN) or further dilutive financings, governance squeeze if new board/management fail to deliver, and extreme illiquidity leading to volatility or pump-and-dump episodes around Admission (~16 Feb 2026). Short-term (weeks–months) risk centers on admission, CLN newsflow and board hires; long-term (12–24 months) value depends on Cascade Studio traction (ARR milestones) and successful deployment of capital. Hidden dependency: Mollyroe’s thesis is levered to a few portfolio outcomes — lack of operational control of portfolio companies magnifies binary outcomes.

Trade implications: Avoid meaningful long exposure to AQSE:MOY pre-admission; consider a small opportunistic short or sell-if-held position (size <=0.25% NAV) from Admission if volume remains low and price <0.005p. Rotate into large-cap AI/creative infrastructure: overweight NVDA (NVDA) +2–4% NAV via 9–12 month 20–25% OTM calls, and Unity (U) +1–2% NAV outright or 6–9 month call spreads; long Adobe (ADBE) 1–2% for content workflows. Pair trade: long U or ADBE, short MOY (or generic AQSE AI microcaps) to capture relative re-rating while hedging market risk; enter on Admission and re-evaluate on any CLN announcement within 30 days.

Contrarian angles: Consensus underestimates the dilution cliff — yet upside exists if management converts the £300k plus CLN into a high-growth stake (e.g., Cascade achieving $5–10m ARR in 12–18 months) that could trigger re-rating; this is low-probability but high-payoff. A contrarian micro-spec long (<=0.1% NAV) could be opened only if two conditions are met post-admission: daily volume >1% of free float and price sustainably >0.005p for five consecutive trading days, or a named strategic investor disclosed with tangible follow-on funding >=£1m. Historical parallels: microcap VC shells often collapse absent material portfolio exits — treat Mollyroe similarly until hard milestones are met.

Key Decisions for Investors

• Reduce or exit existing MOLLYROE (AQSE:MOY) holdings ahead of Admission (target sell by 16 Feb 2026) or size any short position to <=0.25% NAV via borrow/CFD to capitalize on likely post-issue selling pressure; avoid adding new long exposure unless triggers met (volume and price thresholds below).
• Establish overweight positions in large-cap AI/creative infrastructure: NVDA (NVDA) +3% NAV via 9–12 month call options (20–25% OTM) to express structural AI upside; Unity (U) +2% NAV outright or via 6–9 month call spread to play spatial computing tailwinds; Adobe (ADBE) +1–2% NAV for media workflows exposure.
• Implement a pair trade: long Unity (U) or Adobe (ADBE) and short AQSE microcap AI names (including MOY) sized to be delta-neutral to market moves; enter on or within 3 trading days of Admission, size so net exposure to broad market is <25% of position notional.
• Set event-driven triggers to adjust MOY exposure: Reduce shorts or consider tiny speculative long (<=0.1% NAV) only if within 30–90 days management announces a CLN >£1m with a named strategic investor or Cascade Studio posts verifiable ARR >=$5m within 12–18 months; otherwise keep flat-to-short.
• Monitor three specific metrics in next 30–60 days: (1) CLN finalization and terms (dilution cap/convert price), (2) board hires (CEO/CIO named with sector experience), and (3) daily traded volume as % of post-money float — act if volume >1% or CLN implies >£1m new funding.